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Bub1 Kinase Targets Sgo1 to Ensure
Efficient Chromosome Biorientation
in Budding Yeast Mitosis
Josefin Fernius, Kevin G. Hardwick
*
Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, University of Edinburgh, United Kingdom
During cell division all chromosomes must be segregated accurately to each daughter cell. Errors in this process give
rise to aneuploidy, which leads to birth defects and is implicated in cancer progression. The spindle checkpoint is a
surveillance mechanism that ensures high fidelity of chromosome segregation by inhibiting anaphase until all
kinetochores have established bipolar attachments to spindle microtubules. Bub1 kinase is a core component of the
spindle checkpoint, and cells lacking Bub1 fail to arrest in response to microtubule drugs and precociously segregate
their DNA. The mitotic role(s) of Bub1 kinase activity remain elusive, and it is controversial whether this C-terminal
domain of Bub1p is required for spindle checkpoint arrest. Here we make a detailed analysis of budding yeast cells
lacking the kinase domain (bub1DK). We show that despite being able to arrest in response to microtubule
depolymerisation and kinetochore-microtubule attachment defects, bub1DK cells are sensitive to microtubule drugs.
This is because bub1DK cells display significant chromosome mis-segregation upon release from nocodazole arrest.
bub1DK cells mislocalise Sgo1p, and we demonstrate that both the Bub1 kinase domain and Sgo1p are required for
accurate chromosome biorientation after nocodazole treatment. We propose that Bub1 kinase and Sgo1p act together
to ensure efficient biorientation of sister chromatids during mitosis.
Citation: Fernius J, Hardwick KG (2007) Bub1 kinase targets Sgo1 to ensure efficient chromosome biorientation in budding yeast mitosis. PLoS Genet 3(11): e213. doi:10.1371/
journal.pgen.0030213
Introduction
The ﬁdelity of chromosome segregation is dependent upon
correct bipolar attachment of sister chromatids to the spindle
microtubules (for review see [1]). These attachments are
mediated through complex, molecular machines called
kinetochores, which assemble at the centromere of each
chromosome (for reviews see [2,3]). Accurate chromosome
segregation is crucial: any errors lead to aneuploidy, which is
characteristic of many diseases and a hallmark of tumour
progression [4,5]. Cells have evolved a number of control
mechanisms to prevent segregation errors. One of the most
important is the spindle checkpoint, which is a surveillance
system that tightly regulates the metaphase-to-anaphase
transition. It ensures that all kinetochores have established
proper bipolar (also known as amphitelic) attachments, where
sister kinetochores are attached to microtubules emanating
from opposite spindle pole bodies (SPBs), before anaphase is
initiated [3,6,7]. The spindle checkpoint consists of a set of
conserved proteins (Mad1-3p, Bub1p, Bub3p, and Mps1p [8–
10]) that form distinct complexes and localise to unattached
kinetochores in a highly ordered manner [11,12]. The
downstream target of these proteins is Cdc20p [13,14], an
activator of the E3 ubiquitin ligase known as the Anaphase
Promoting Complex or Cyclosome (APC/C) (for review see
[15]). Securin (Pds1p in budding yeast) and cyclin B are the
key APC/C substrates and polyubiquitination of these, and
their ensuing proteolytic destruction, is required for ana-
phase onset and mitotic exit [16–18]. Thus when the spindle
checkpoint is active, the APC/C is inhibited, Securin levels
remain high, and anaphase onset is delayed.
The spindle checkpoint responds to unattached kineto-
chores [19,20] and to lack of tension across sister kineto-
chores that have yet to achieve proper biorientation [21].
These two responses are linked through the Aurora B kinase
homologue, Ipl1p (see [22] for review). Ipl1p is not required
to activate the spindle checkpoint in the response to
unattached kinetochores induced by antimicrotubule drugs,
but is required to respond to a lack of tension [23]. Ipl1p
recognises and breaks defective or inappropriate kineto-
chore-microtubule attachments, which lack tension, and
thereby creates unattached kinetochores [24]. In addition,
Ipl1p-dependent phosphorylation of Mad3p ensures full
inhibition of Cdc20-APC/C in cells with reduced cohesion
[25].
Other protein kinases (Bub1, BubR1, and Mps1) also play
an integral part in the spindle checkpoint (see [6]). Bub1p is a
conserved protein kinase, which is essential for spindle
checkpoint arrest. Bub1p forms a complex with Bub3p [26],
binds Mad1p when the checkpoint is active [27], and is
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required for localisation of several checkpoint proteins to
unattached kinetochores [12,28,29]. It is well established that
the N-terminal domains of Bub1p, which include the
kinetochore targeting and Bub3p-binding domains, are
required for spindle checkpoint arrest [29,30]. However the
role of the C-terminal kinase domain remains elusive,
although it has been suggested that phosphorylation of
Cdc20 by human Bub1 is required to enhance the inhibition
of APC/C [31]. Several lines of evidence suggest role(s) for
Bub1 in addition to its spindle checkpoint function. Bub1 is
required for accurate chromosome segregation in both
budding and ﬁssion yeasts [29,30] and to maintain ploidy in
ﬁssion yeast [32]. In addition, there is evidence that Bub1
plays a role in chromosome congression in mammalian cells
[28,33].
In this paper we characterise the role of the Bub1p kinase
domain in budding yeast mitosis. We show that bub1DK cells
die rapidly in the presence of microtubule drugs despite
being able to initiate and maintain a spindle checkpoint
arrest. This rapid cell death is due to chromosome mis-
segregation following release from antimicrotubule drugs. In
addition, we demonstrate a role for Bub1 kinase in accurate
Sgo1p localisation to mitotic centromeres. Sgo1p is the sole
budding yeast member of the Shugoshin/MEI-S332 family (for
review see [34]). Members of this family are important
protectors of centromeric cohesion, particularly in meiosis
[35–38]. However, budding yeast Sgo1p does not regulate
cohesion in budding yeast mitosis, and it has been proposed
that this protein is a tension sensor at kinetochores [39]. Here
we demonstrate that the Bub1 kinase domain and Sgo1p act
together to ensure efﬁcient chromosome biorientation.
Results
Although Bub1 kinase activity has been shown to be
required for accurate chromosome segregation in both
budding and ﬁssion yeasts [29,30], the roles of the Bub1
kinase domain have not been clearly established. Indeed, it
remains controversial whether the kinase activity is required
for a spindle checkpoint arrest, in either organism. In some
budding and ﬁssion yeast reports, Bub1 kinase activity was
thought to be necessary for checkpoint arrest [26,40], but in
others it was not [29,30]. This controversy might partly be due
to the use of a ‘‘kinase-dead’’ point mutation (K733R), which
has since been shown to destabilise budding yeast Bub1p [30]
and could therefore display a phenotype similar to that of a
bub1D. We generated a novel K733M kinase-dead allele, but
found that this protein was also unstable (K. G. Hardwick,
unpublished data). Therefore, we chose to carry out a detailed
analysis of the role of the Bub1 kinase domain by using a
truncated Bub1 kinase allele (containing amino acids 1–608)
in Saccharomyces cerevisiae. This allele lacks the whole kinase
domain and has already been shown to express a stable
protein [30], and to efﬁciently bind Bub3p and Mad1p [27]. A
similar Bub1 truncation is stable and is able to localise to
kinetochores in S. pombe ([40] and V. Vanoosthuyse, personal
communication).
Cells Lacking the Bub1 Kinase Domain Die Rapidly in the
Presence of Microtubule Depolymerising Drugs
Spindle checkpoint mutants are hypersensitive to micro-
tubule destabilising drugs because of their inability to arrest
in metaphase in response to unattached kinetochores. The
precocious separation of sister chromatids gives rise to
unequal segregation of chromosomes and aneuploidy, which
is lethal in yeast. On rich media containing low concen-
trations of the microtubule drug benomyl, bub1DK cells
showed an intermediate sensitivity to the drug compared to
other spindle checkpoint mutants. For example, it was clear
that the bub1DK mutation was not as benomyl sensitive as the
complete bub1D but that it was more sensitive than mad3D
(Figure 1A). Spindle checkpoint mutants die rapidly in liquid
cultures containing microtubule drugs [41], so we asked how
long bub1DK cells remain viable under such conditions. Cells
were grown in liquid media containing 30 lg/ml nocodazole
and then plated on rich media lacking microtubule drugs.
Viability was scored as the percentage of cells able to form
colonies. In contrast to wild-type cells, bub1DK behaved like
bub1D and mad2D cells and showed rapid death in this viability
assay (Figure 1B). After 1 h, 55% of bub1DK cells were already
inviable. These data show that cells lacking the Bub1 kinase
domain are sensitive to microtubule drugs and that they die
rapidly, but that bub1DK is not a complete loss of function
(null) allele.
The Bub1 Kinase Domain Is Dispensable for a Robust
Spindle Checkpoint Arrest in Response to Unattached
Kinetochores
bub1DK cells could be sensitive to microtubule depolymer-
ising drugs for various reasons. They may be unable to arrest
in mitosis, or they may fail to recover properly after spindle
checkpoint arrest. To distinguish between these possibilities,
we examined cell morphology and the level of sister-
chromatid cohesion in bub1DK cells in response to micro-
tubule drugs. First we performed a morphological assay
scoring rebudding of cells on plates containing 20 lg/ml and
80 lg/ml benomyl (see Figure S1). Both wild-type and bub1DK
cells remained large-budded (which is an indication of
mitotic arrest) for up to 6 h on benomyl, compared to the
spindle checkpoint mutants, mad2D and bub1D, which did not
respond to microtubule depolymerisation and rebudded
prematurely. This conﬁrms the previous report of a large-
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Author Summary
Many human diseases, including birth defects and cancer, are
associated with aneuploidy. This is where cells have an incorrect
number of chromosomes, because of a failure to segregate their
genetic material accurately during cell division. Cells employ many
control mechanisms to ensure an extremely high fidelity of
chromosome segregation. One way that they do this is to hold
the replicated copies of their chromosomes (known as sister
chromatids) together until they are all attached properly to
microtubules of the mitotic spindle. All pairs of sister chromatids
must have one sister attached to each of the two spindle poles, a
process known as biorientation. Here we demonstrate that the Bub1
kinase domain acts to target Sgo1 to budding yeast centromeres,
and that both of these proteins are required for efficient
biorientation of chromosomes in yeast mitosis. Bub1 kinase and
Sgo1 functions become particularly important during spindle
reassembly after antimicrotubule drug treatment. We propose that
this is because the mutant cells fail to respond to kinetochores that
are not under tension, and that they are unable to correct syntelic
attachments where both sister chromatids attach to microtubules
from the same spindle pole.
budded arrest for bub1DK cells in nocodazole [30]. To
monitor sister-chromatid cohesion directly, we used strains
expressing lacI-green ﬂuorescent protein (GFP) and contain-
ing a lac-operator array on Chromosome IV, thereby marking
this chromosome with GFP. This enabled us to visualize
whether chromatids were still cohesed (one GFP dot) or had
separated prematurely (two GFP dots) in the presence of
antimicrotubule drugs. Cells were synchronized in G1, using
the mating pheromone a-factor, and released into media
containing nocodazole. bub1DK cells behaved like wild type
and efﬁciently maintained sister-chromatid cohesion for 3 h
in cultures containing nocodazole (Figure 1C). As a ﬁnal test
of mitotic arrest, we asked whether Securin (Pds1-myc) was
stabilized in the presence of nocodazole in bub1DK cells. This
was the case (Figure 1D), conﬁrming that the bub1DK cells
efﬁciently respond to microtubule depolymerisation and
initiate and maintain a robust spindle checkpoint arrest.
The Bub1 Kinase Domain Is Necessary for the Checkpoint
Response to Reduced Cohesion
In the assays described above, we used antimicrotubule
drugs to activate the spindle checkpoint pathway that
recognizes unattached kinetochores. Complete microtubule
depolymerisation is not a very common physiological
situation, and we were therefore interested to analyse bub1DK
cells in other situations. Ipl1 kinase activates the spindle
checkpoint by creating unattached kinetochores in response
to mutations in several kinetochore components that were
thought to create reduced tension at centromeres [24]. We
wondered whether the kinase domain of Bub1 is required to
arrest cells containing such defective kinetochores. In
contrast to an ipl1–321, mtw1–1 double mutant, cells
containing the mtw1–1 mutation in combination with bub1DK
were able to respond to the kinetochore defect and stabilise
Pds1-myc (Figure 2A). Similar results were obtained when
using the more severe ndc80–1 kinetochore mutant in
combination with bub1DK (unpublished data). These results
show that Bub1 kinase is not required to ‘‘sense’’ these
defective kinetochores, nor to activate Ipl1p in these mutants,
nor to respond to the unattached kinetochores that Ipl1p
kinase activity creates.
Ipl1p (Aurora kinase), Mad3p phosphorylation, and Sgo1p
have all been demonstrated to be necessary for the
checkpoint response to reduced cohesion, even though they
are not necessary for the response to unattached kineto-
chores [23,25,39]. To test whether the Bub1 kinase domain is
necessary for the response to reduced cohesin, bub1DK,GAL-
MCD1 cells were synchronised in G1, depleted for cohesin by
turning off MCD1 expression with glucose addition, and then
Figure 1. Cells Lacking Bub1 Kinase Domain Show Sensitivity to Microtubule Depolymerising Drugs despite Being Spindle Checkpoint Proficient
(A) Wild-type (KH186), mad1D (MB076),mad2D (KH141), mad3D (KH173), bub1D (KH127), bub3D (MB003), and bub1DK (JF098) strains were plated out in
10-fold serial dilutions on YPDA media or on YPDA media containing 8 lg/ml benomyl.
(B) The indicated strains were grown in YPDA media containing 30 lg/ml nocodazole, and the viability of the cells was measured as percentage of cells
able to form colonies on YPDA media lacking microtubule drugs.
(C) Wild-type (JF004), bub1DK (JF125), bub1D (JF140), and mad3D (EK013) strains containing a GFP-marked chromosome were synchronised in G1 using
a-factor, then released into YPDA with 30 lg/ml nocodazole at 23 8C. We tested ability of the cells to maintain a spindle checkpoint arrest by scoring
cells that could keep their GFP-marked sister chromatids cohesed for 3 h in nocodazole (i.e., one GFP dot). The percentage of cells with two GFP dots
was counted at the release from G1 (grey bars) and after 3 h in nocodazole (black bars) (n¼ 100 cells for each repeat experiment). Error bars indicate
standard deviation.
(D) Wild-type (JF004) and bub1DK (JF125) strains containing Pds1-18myc were arrested in G1 using a-factor and synchronously released into YPDA
media or YPDA media containing 30 lg/ml nocodazole at 23 8C. Samples were taken at indicated times. Levels of Pds1 were monitored by
immunoblotting using A14 a-myc antibody and a-PGK1 as a loading control.
doi:10.1371/journal.pgen.0030213.g001
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released into the cell cycle. Immunoblotting for Securin levels
(Pds1) showed that neither bub1DK nor sgo1mutants were able
to maintain a metaphase arrest as well as wild-type cells
(Figure 2B). They did not degrade Pds1p quite as quickly as
the mad2D control, but we believe that was because they grow
more slowly, most likely because of their aneuploidy
phenotype. We also analysed the ability of bub1DK cells to
grow in the presence of poorly segregating linear chromo-
somes. Such chromosomes have been shown to delay mitosis
in a checkpoint-dependent manner [42] and were employed
in a screen that identiﬁed sgo1 alleles [39]. For the screen, the
linear chromosome-induced delay becomes lethal as the
strains also contain CDC28-VF, a mutation in CDC28/CDK1
that reduces APC activity. This lethality is rescued by
checkpoint mutations, as no mitotic delay is imposed. Figure
2C shows that bub1DK cells grow far better than wild type in
the presence of the short linear chromosomes, indicating that
this checkpoint response is also defective. We conclude that
whilst the Bub1 kinase domain is not necessary for the
response to unattached or defective kinetochores, it is
necessary for the budding yeast checkpoint response to a
lack of tension at mitotic kinetochores.
The above experiments strongly suggest that the C-
terminal kinase domain of Bub1 is not required to initiate
or maintain spindle checkpoint arrests induced by unat-
tached or defective kinetochores, but that it is necessary to
respond to a lack of tension. The bub1DK phenotype closely
mirrors that of sgo1D, which is also necessary for the tension
response [39] but not the response to mtw1–1- or ndc80–1-
induced kinetochore defects [24]. The bub1DK and sgo1D
phenotypes differ from that displayed by ipl1 mutants. Ipl1p
is required for the tension response but also for the response
to mtw1–1- or ndc80–1-induced kinetochore defects [24], and
Ipl1p is an essential protein [43].
The Bub1 Kinase Domain Plays a Role in Sgo1 Localisation
Bub1p is important for Sgo1p localisation at centromeres
in meiosis in budding and ﬁssion yeast [36,37,44] and
regulates Sgo1 localisation in mitosis in human cells [45,46].
Because of this and the similarity in the bub1DK and sgo1D
phenotypes, we tested whether the Bub1 kinase domain has a
role in localising Sgo1p to kinetochores in budding yeast
mitosis. Unfortunately Sgo1-GFP gives a rather weak signal,
so we did this by performing immunoﬂuorescence on ﬁxed
chromosome spreads. We used a strain containing Ndc10-
6HA to label kinetochores and asked whether Sgo1-9Myc
colocalised with Ndc10p in wild type, bub1D, and bub1DK cells.
We analysed unbiased populations of cycling cells (see Figure
S2) and cultures that had been arrested in mitosis for 3 h with
nocodazole. Whilst wild-type cells showed multiple foci with
Figure 2. Bub1 Kinase Domain Is Required to Arrest in Response to Reduced Cohesion
(A) Wild-type (JF004), mtw1–1 (SBY1646), mtw1–1, bub1DK (JF100), and mtw1–1, ipl1-321 (SBY1724) strains carrying the temperature-sensitive allele
mtw1–1 and Pds1-18Myc were synchronised in G1 for 2.5 h then incubated at the restrictive temperature 36 8C for 30 min before release. The levels of
Pds1 were monitored by immunoblotting with A14 anti-myc antibody and anti-PGK1 as a loading control.
(B) Wild-type (VBI545), bub1DK (JF023),mad2D (VBI560), and sgo1D (JF224) strains, containing Pds1-myc, were synchronised in G1 with a-factor in media
containing 2% galactose and 2% raffinose to maintain Mcd1 expression. Mcd1 was then turned off by incubating them in media containing glucose and
a-factor for 3 h. The cells were then released into rich media containing glucose, and samples for immunoblotting were taken at indicated times. Pds1
and PGK1 levels were monitored as previously described.
(C) Wild-type (YBS151), bub1DK (JF110), and mad2D (YBS406) strains, carrying a LEU2-marked linear minichromosome (LMC) were plated in 10-fold serial
dilutions onLEU plates and onLEU plates with 10 lg/ml doxycycline. In this strain doxycycline represses a dominant CDC20 allele that is insensitive
to the spindle checkpoint proteins [13]. Therefore this CDC20 allele makes cells insensitive to the presence of LMCs. These LMCs are thought to be
unable to withstand spindle forces and separate producing kinetochore-microtubule attachments that are no longer under tension. In the presence of
doxycycline, wild-type cells grow very poorly because of their checkpoint response to the LMCs, but the bub1DK mutant grows far better, indicating
that their ability to respond to attachments lacking tension is impaired.
doi:10.1371/journal.pgen.0030213.g002
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overlapping localisation for Sgo1p and Ndc10p in many
spreads, this was rarely the case for bub1DK cells (Figure 3A).
Categorization revealed such colocalisation of Sgo1p and
Ndc10p in only 13% of mutant cells (compared with 2% in
wild type). In bub1DK cells there were often one or at most
two bright punctate signals for Sgo1p. To determine whether
these could be SPBs, we carried out double label staining for
Sgo1-9Myc and the 110-kD component of the SPB. Colocal-
ization was observed in many cells (Figure 3B), suggesting that
signiﬁcant levels of Sgo1p localise to the SPB in the bub1DK
mutant. We cannot rule out the possibility that some of this
signal is due to centromeres that remain associated with the
SPB in these nocodazole-treated cells. To conﬁrm the
decreased association of Sgo1p with kinetochores in bub1DK
cells, we employed chromatin immunoprecipitation (ChIP).
We reproducibly observed decreased association of Sgo1p
and centromeres, using both centromeric and pericentro-
meric primer sets, in bub1DK cells (Figure 3C–3E).
These results conﬁrm that the kinase domain of Bub1p
plays an important role in localising Sgo1p to budding yeast
centromeres in mitosis. This could explain why the sgo1D and
bub1DK strains display such similar phenotypes.
bub1DK Cells Mis-Segregate Chromosomes during
Recovery from a Checkpoint Arrest
The fact that bub1DK cells are hypersensitive to antimicro-
tubule drugs, yet able to arrest efﬁciently, suggested to us that
the Bub1 kinase domain could be required for proper
recovery from spindle damage. To test this, we ﬁrst asked
whether they have increased chromosome loss following
nocodazole arrest. We followed chromosome segregation
during the ﬁrst anaphase after nocodazole release, using the
GFP-marked chromosome strain described above. Accurate
chromosome segregation should give rise to one GFP spot in
each daughter cell. We arrested cells in metaphase for 3 h
with nocodazole then released them into anaphase. After 30
min, cells were ﬁxed and stained with a-tubulin antibody to
monitor spindle elongation. The results showed 33% mis-
segregation of the GFP-marked chromatids in bub1DK cells
(Figure 4A, lower panel) compared to 0.2% in wild type
(Figure 4A, upper panel).
We then used the same strain to score a large number of
cells for chromosome mis-segregation and compared un-
challenged G1 cells with G1 cells that had been released from
a nocodazole arrest. Cells were arrested in G1 using a-factor,
and the number of cells with one GFP foci (Figure 4C, empty
triangle) versus two GFP foci (ﬁlled triangle) were counted. As
expected, most cells had one GFP dot, representing one copy
of Chromosome IV, in both wild-type (0% had two GFP dots,
n¼400) and bub1DK cells (2% had two GFP dots, n¼400). The
small number of bub1DK cells with two copies of this
chromosome (Figure 4B) reﬂects a background level of
aneuploidy, frequently observed in bub1 mutants. However,
when cells were released from G1 into media containing
nocodazole for 3 h, then released and trapped in the
following G1, there was a marked increase in the number of
cells containing two GFP foci in bub1DK (30% had two GFP
dots, n¼ 400) compared to wild type (where only 4% had two
GFP dots, n¼ 400) (Figure 4C). This conﬁrms that there was a
signiﬁcant defect in segregating this chromosome faithfully
during the anaphase following nocodazole release. Because of
the high incidence of chromosome mis-segregation following
treatment with nocodazole, and considering that we only
scored one of 16 budding yeast chromosomes in this analysis,
we propose that the reason why bub1DK cells are sensitive to
antimicrotubule drugs, despite showing capacity to arrest in
metaphase, is because of chromosome loss.
To more accurately quantitate their chromosome-loss rate,
and to compare it with that of sgo1D mutants, we employed
sectoring assays, which have previously been used to analyse
many mitotic and checkpoint mutants [30,47]. We used a
strain containing a nonessential test chromosome that carries
the SUP11 (ochre-suppressing tRNA) gene that makes
colonies that are normally red, because of the ade2–1
mutation, white. We scored loss of this chromosome at the
ﬁrst division by counting colonies that are half red and half
white. Consistent with published data [30], in an unchallenged
cell cycle, bub1D cells lost the test chromosome at a rate of 41
per 1,000 divisions compared to 0.5 per 1,000 in wild type.
bub1DK cells also showed chromosome loss in a normal
mitosis, but at a lower rate than bub1D, at 28 per 1,000
divisions (Figure 4E). The loss rate in sgo1D was very similar:
32 per 1,000 divisions.
If the Bub1 kinase domain and Sgo1p carry out the same
function, one might predict little, if any, synthetic phenotype
when combining the two mutations in bub1DK, sgo1D cells.
Alternatively, if the double mutant was signiﬁcantly sicker
then that would suggest that the Bub1 kinase domain has
other functions, in addition to Sgo1p targeting. Our analysis
of the double mutant, both in terms of sensitivity to
microtubule drugs and chromosome-loss rates, strongly
supports the former option. We found that the double
mutant is no more benomyl sensitive than the bub1DK strain
(Figure 4D) and that the rate of chromosome loss was no
higher than that of the bub1DK and sgo1D single mutants
(Figure 4E).
These results show that the Bub1 kinase domain plays a role
in chromosome segregation that becomes very important
upon challenge with microtubule drugs. The lack of a
synthetic genetic interaction suggests that the Bub1 kinase
domain function is closely related to that of Sgo1p, consistent
with the idea that the major role of the kinase is to efﬁciently
target Sgo1p to centromeres (Figure 3). Note, bub1D cells have
an even higher chromosome-loss rate because, in addition to
their segregation defects, these cells have also lost their ability
to checkpoint arrest.
The Bub1 Kinase Domain Ensures Proper Chromosome
Biorientation
As bub1DK cells have chromosome segregation defects, we
tested whether they displayed kinetochore attachment
defects. To do this we employed a bub1DK strain containing
Tub1-cyan ﬂuorescent protein (CFP) to label spindle micro-
tubules and Mtw1-3xGFP to mark all kinetochores. Cells were
arrested in mitosis with benomyl and nocodazole, which were
then washed out, and the ensuing anaphase analysed. We
identiﬁed no more unattached kinetochores (indicated by
Mtw1-GFP foci off the spindle axis) in bub1DK cells than in
wild-type cells (8%, see Figure 5A). Similar results, with low
levels of unattached kinetochores, were obtained for sgo1D
cells. ndc80–1 mutants were used as positive controls for this
experiment, and as expected these contain many unattached
kinetochores at their restrictive temperature (Figure 5A
[24,48]). From this we conclude that bub1DK and sgo1D cells
PLoS Genetics | www.plosgenetics.org November 2007 | Volume 3 | Issue 11 | e2132316
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Figure 3. Bub1 Kinase Domain Is Necessary for Accurate Sgo1 Localisation to Kinetochores
(A) Wild-type (AMY1110) and bub1DK (JF038) strains containing Sgo1-9Myc and Ndc10-6HA (to mark the kinetochores) were arrested in metaphase with
15 lg/ml nocodazole and 30 lg/ml benomyl at 23 8C for 3 h. Chromosome spreads were performed and stained with a-myc antibody (CM-100), a-HA
antibody (HA11), and DAPI to recognize the DNA. Spreads with clear Ndc10-6HA staining were categorized as showing colocalization with Sgo1-9myc
only if they contained multiple (.2) overlapping foci. Fifty spreads per strain were analysed.
(B) Sgo1-9myc colocalises with the SPB in the bub1DK mutant. Spreads were prepared as in (A) and stained with a-myc antibody, anti-Spc110 antibody
to detect SPBs, and DAPI. Scale bar represents 2 lm.
(C) Schematic of primers sets for Sgo1-6HA ChIP analysis showing the CEN3, centromeric region; R3, pericentromeric region; and c281, the negative arm
region.
(D) PCR on ChIPs of ‘‘no tag’’ (KH186), Sgo1-6HA (AMY209), and bub1DK, Sgo1-6HA (JF211) strains arrested with 15 lg/ml nocodazole and 30 lg/ml
benomyl at 23 8C for 3 h, showing reduced Sgo1p levels associated with CEN3 and R3 regions in the bub1DK mutant compared to wild type.
(E) The graph shows quantification of the ChIP data from the ‘‘no tag’’ (KH186), wild-type (AMY209), and bub1DK (JF211) strains. The ‘‘binding ratio’’
was calculated as a ratio of the ChIP PCR signal to the PCR signal from a 1:500 diluted input fraction. The error bars indicate standard deviation (SD) of
the mean from five different PCR reactions from two separate experiments.
doi:10.1371/journal.pgen.0030213.g003
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do not display signiﬁcant numbers of unattached kineto-
chores, even after spindle ablation and re-formation.
Next we wanted to test whether the bub1DK cells contain
more subtle kinetochore attachment problems, such as
defects in biorientation. If, during spindle reassembly, both
sister kinetochores attach to microtubules from the same
spindle pole (syntelically) perhaps the bub1DK cells would be
unable to detect or correct this defect. Note syntelic attach-
ments are unlikely to result in tension across sister
kinetochores. To test this possibility, we used strains that
carry an array of tet operators integrated only 2 kb from the
centromere on Chromosome IV and express a Tet repressor-
GFP fusion protein. In addition, their spindle poles are
marked with Spc42-tomato, and the strain has a methionine
repressible promoter for CDC20 (pMET-CDC20). By depleting
Cdc20p, we can induce a metaphase arrest that is independ-
ent of spindle damage and the checkpoint. Using such strains
we could directly test the ability of cells to establish proper
bipolar attachment after nocodazole treatment. Amphitelic
attachments were visualised as pairs of GFP-centromere
(CEN) spots pulled apart by the microtubule forces of the
bipolar spindle (see Figure 5B) [49–51], whereas monotelic or
syntelic attachments (both monopolar) remained as single
GFP-CEN spots, on the spindle axis. Cells were arrested in G1,
depleted of Cdc20p, and then released into media containing
benomyl and nocodazole for 3 h. The microtubule drugs were
Figure 4. bub1DK Cells Display High Levels of Chromosome Mis-segregation upon Nocodazole Release
(A) Wild-type (JF004) and bub1DK (JF125) cells were released from G1 into media containing 30 lg/ml nocodazole and incubated at 23 8C for 3 h. Cells
were subsequently released into anaphase by washing out the nocodazole. Samples were fixed in 3.7% formaldehyde for 1 h, 30 min after release, and
stained with a-GFP (GFP-marked chromosome) and a-tubulin (red spindle) antibodies. DNA was stained with DAPI (blue). Percentage of nondisjunction
of the GFP-marked chromatid at the first anaphase following nocodazole arrest was 2% in wild-type cells and 33% in bub1DK cells (n  50 anaphase
cells). Scale bar represents 3 lm.
(B) Wild-type (JF004) and bub1DK (JF125) strains were synchronised in G1 as previously described and cells with one GFP dot (empty triangle) versus
two dots (filled triangle) were counted (n¼ 400). Scale bar represents 2 lm.
(C) Cells from (B) were then released and incubated in media containing 30 lg/ml nocodazole at 23 8C for 3 h and released into media containing a-
factor to score cells in the following G1. The number of cells with one GFP dot versus two dots were scored (n ¼ 400).
(D) Wild-type (KH186), bub1D (KH127), bub1DK (JF098), sgo1D (JF188), and bub1D, sgo1D (JF185) strains were plated out in 10-fold serial dilutions on rich
media and on rich media containing 8 lg/ml benomyl.
(E) Strains carrying the SUP11 artificial chromosome were grown overnight in CSM-URA media, then diluted back to OD600 0.2 and grown in YPDA media
at 30 8C for 3 h. Cells were then plated out on YPD at a density of ;500 cells per plate. Only colonies that were at least half red were scored for losing
the test chromosome at the first division.
doi:10.1371/journal.pgen.0030213.g004
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then washed out, cells kept in metaphase by continued
repression of Cdc20p, and the level of biorientation was
scored as two GFP dots in between two red SPBs (ﬁlled white
triangle, Figure 5C). This procedure gave us the relative levels
of biorientation, although these numbers will be under-
estimated, since, at the time of ﬁxation, some cells that have
established biorientation will only show one GFP dot because
of the ‘‘breathing’’ characteristics of mitotic centromeres
[49,50]. Quantitation of these images revealed a signiﬁcant
defect in establishing proper biorientation in both bub1DK
and sgo1D mutants, after nocodazole release, indicating that
Bub1 kinase and Sgo1p both work to ensure efﬁcient
chromosome biorientation (Figure 5D). In addition, the
bub1DK,sgo1D double mutant showed a very similar quantita-
tive defect in biorientation to the two single mutants,
suggesting that the Bub1 kinase domain and Sgo1p are
necessary for the same biorientation function.
The position of the chromosomes in these images, relative
to the SPBs (Figure 5E), is consistent with them being
syntelically attached: both sisters are attached to the same
spindle pole and therefore localise very close to it. We have
carried out live-cell analysis of these cells (unpublished data)
in which we scored the numbers of cells in which the GFP-
marked chromosomes were ‘‘breathing’’ on a short mitotic
spindle. Whilst 88% of chromosomes were observed to
breathe in wild-type cells, only 56% did in the bub1DK and
sgo1D mutants during the time observed. We conclude that
these chromosomes are most likely syntelically attached,
rather than being amphitelic attachments that fail to be
stretched, and that the bub1DK and sgo1D mutants are unable
to correct these attachments. Such a defect could account for
much of the chromosome loss detailed in Figure 4. These
ﬁndings agree well with recent live-cell imaging from the
Murray lab showing that sgo1–100 mutants frequently fail to
correct syntelic attachments [52].
Discussion
Bub1 Kinase Is Not Required for Most Spindle Checkpoint
Arrests, but Is Required for the Response to Reduced
Cohesion
In this study we have carried out a detailed analysis of
whether the kinase domain of Bub1 is required for a robust
spindle checkpoint, using a truncated Bub1 kinase allele.
Note, our truncation removes the last 413 residues of Bub1p
(residues 609–1,021), which include 83 residues before the
start of the conserved kinase domain. bub1DK cells showed
sensitivity to benomyl, although not as severe as bub1D cells,
and died rapidly in a nocodazole viability assay. However, our
data clearly show that the Bub1 kinase domain is not required
to initiate or maintain spindle checkpoint arrests induced by
unattached or defective kinetochores. Robust arrests were
observed in the presence of antimicrotubule drugs (either
benomyl or nocodazole), and in the mtw1–1 and ndc80–1
kinetochore mutants (Figure 2A). In addition, we have found
that the Bub1 kinase domain is unnecessary for the arrest
induced by overexpression of the Mps1 protein kinase (GAL-
MPS1, unpublished data and [53]). Thus, the Bub1 kinase
domain is not necessary for a wide range of spindle
checkpoint arrests.
However, like Sgo1p [39] and Ipl1p [23], the Bub1 kinase
domain is necessary to delay anaphase onset in cells with
reduced cohesion (Figure 2B). The simplest interpretation of
this result is that these three functions are all needed for the
checkpoint response to a lack of tension at kinetochores.
The Sensitivity of bub1DK Cells to Microtubule Drugs Is
Due to Chromosome Mis-Segregation after the Release
from Nocodazole
In agreement with previous work [30] we found that
bub1DK cells display chromosome mis-segregation in an
unperturbed mitosis, at a level between those of wild-type
and bub1D cells. The bub1DK chromosome-loss rate becomes
far higher upon spindle damage (Figure 4). We have also
demonstrated that bub1DK cells die rapidly when released
from nocodazole. Importantly, this was not because of an
inability to arrest in nocodazole, but rather to an inability to
segregate chromosomes accurately upon spindle reassembly
(see Figures 4 and 5). We propose that the Bub1 kinase
domain has a role in regulating chromosome segregation
every cell cycle, and that this role becomes particularly
important after spindle damage. Such segregation defects
could reﬂect the inability of bub1DK cells to respond to a lack
of tension at kinetochores (Figure 2).
Our genetic studies support the idea that Bub1 kinase and
Sgo1p act in the same pathway: whilst the complete gene
Figure 5. bub1DK and sgo1D Cells Show Defects in Establishment of Chromosome Biorientation
(A) We analysed the indicated strains for unattached kinetochores following nocodazole treatment. Wild-type (SBY4340), bub1DK (JF123), sgo1D (JF202),
and ndc80–1 (SBY4342) cells were arrested in media containing 30 lg/ml benomyl and 15 lg/ml nocodazole for 3 h at 23 8C. The microtubule drugs
were then washed out three times and released into rich media at 30 8C for 20 min. The control ndc80–1 cells were grown at 36 8C for 1 h before
fixation. Cells were then fixed in 3.7% formaldehyde for 5 min. We scored cells with kinetochores (Mtw1-3GFP staining) off the spindle axis as
‘‘unattached kinetochores.’’ All strains, apart from the ndc80–1, had mostly attached kinetochores aligned on the spindle. A total of 8% of wild-type cells
contained unattached kinetochores at this timepoint (n¼212); bub1DK, 8% (n¼252); and sgo1D, 4% (n¼157) compared to ndc80–1, which had 79% (n
¼ 96) unattached kinetochores. Right hand panel shows examples of unattached kinetochores for each strain. Scale bar represents 2 lm.
(B) Schematic of the principle of the experiment showing GFP marked centromere ‘‘breathing’’ upon chromosome biorientation (i.e., two green dots).
(C) Images of separated SPBs (Spc42-Tomato) containing either one GFP foci in between two SPBs (empty white triangle, scored as nonbioriented) or
one GFP foci by one SPB (red empty triangle, scored as nonbioriented) or finally two GFP foci between two SPBs (filled triangle, scored as bioriented
chromosome). Scale bar represents 2 lm.
(D) Wild-type (JF152), bub1DK (JF154), sgo1D (JF156), and bub1DK,sgo1D (JF202) strains carrying cenIV-GFP, Met-Cdc20, and Spc42-Tomato were
synchronised in G1 for 3 h and then depleted for Cdc20 by incubating them in a-factor and 8 mM methionine for 2 h before releasing them into media
containing 30 lg/ml benomyl, 15 lg/ml nocodazole, and 8 mM methionine at 23 8C for 3 h. The nocodazole was then washed out and samples were
taken at indicated times. Only cells that had separated SPBs were counted for each sample (n¼ 100) and scored for biorientated chromatids (two GFP
foci between two SPBs) versus nonbioriented chromatids (one GFP foci between two SPBs and one GFP foci by one SPB). Error bars indicate standard
deviation. Standard deviations are based on five separate experiments with all strains apart from sgo1D,bub1DK double mutant strain, which was used
in two separate experiments.
(E) This graph represents the cells in which the single GFP dot resided next to the SPB (red triangle) as opposed to in between the SPBs (white empty
triangle), calculated as a percentage of the total cells with only one GFP dot. The data plotted are the average from two separate experiments.
doi:10.1371/journal.pgen.0030213.g005
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deletions, bub1D and sgo1D are synthetically sick [35], we could
detect no signiﬁcant synthetic interaction between bub1DK
and sgo1D in chromosome-loss rate (Figure 4E) sensitivity to
antimicrotubule drugs (Figure 4D) or in the biorientation
assay (Figure 5D). The simplest interpretation is that the
important functions of Bub1 kinase are all Sgo1-dependent,
and therefore already defective in the sgo1D. We propose that
the complete gene double deletion (bub1D,sgo1D) is sicker
because they are also unable to checkpoint arrest, which is
supported by the ﬁnding that mad2D and sgo1D are also
synthetically very sick [35].
Sgo1p Is Mislocalised in bub1DK Cells
The close resemblance of the phenotypes between bub1DK
and sgo1D cells encouraged us to investigate further whether
they are part of the same pathway. Our data indicate that in
budding yeast mitosis the kinase domain of Bub1p does play
an important role in accurate Sgo1p localisation (Figure 3).
Chromosome spreads and ChIP show that there were reduced
levels of Sgo1 at centromeres, in strains lacking the Bub1
kinase domain.
In some experiments a slight increase in Sgo1p levels was
observed on chromosome arms. If true for the chromosome
as a whole, this ﬁnding would be consistent with observations
in tissue culture where depletion of hsBub1 lead to hsSgo1
localizing to the chromosome arms [45]. In vertebrates this
protects cohesion along the chromosome arms and perturbs
sister-chromatid separation. However, in budding yeast there
is no evidence that Sgo1 protects cohesin in mitotic cells, and
when we analysed cohesin (Mcd1) cleavage in our bub1DK
mutant (Figure S3) we saw no signiﬁcant effect. General
chromosome staining was not apparent in spreads of mitotic
bub1DK cells, but we did frequently observe Sgo1p at spindle
poles. The reason for this SPB localisation is currently
unclear.
Overall, our data agree with work from other groups
showing a role for Bub1 in localisation of Sgo1 to
centromeres in mitosis in human cells [45,46], and in ﬁssion
yeast [36]. Data are also in agreement with the ﬁnding that
Bub1 kinase activity is required for centromeric localisation
of Sgo1p (and the protein phosphatase PP2A sub-unit Rts1p)
in budding yeast meiosis [44]. That study also showed that
Bub1p localisation is independent of Sgo1p and PP2A [44].
Is Sgo1 a Bub1 Kinase Substrate?
Because sgo1D and bub1DK cells have such similar pheno-
types and Sgo1p is mislocalised in bub1DK, Sgo1p is a strong
candidate to be a mitotic Bub1 kinase substrate. We have
carried out preliminary experiments showing that Sgo1p is a
phosphoprotein, but there is little if any effect on the
phosphorylation state of Sgo1p in bub1DKmutants (J. Fernius,
unpublished data). We also failed to observe a gel mobility
change for ﬁssion yeast Sgo2p in bub1 mutants (V. Vanoos-
thuyse, personal communication). Therefore we think it is
likely that there is an unknown Bub1 kinase substrate (Factor
X in our models, see Figure 6) that is required for Sgo1p
targeting to centromeres.
Amongst the candidates for Factor X are the Chromoso-
mal Passenger proteins (Aurora B, INCENP, and Survivin, see
[54] for review). In Drosophila meiosis, incenp mutants perturb
MEI-S332 (Sgo) localisation, and MEI-S332 was shown to be a
good Aurora B substrate [55]. In budding yeast meiosis, Ipl1
kinase and the monopolin complex are key regulators of
kinetochore orientation [56]. However, only partial pertur-
bation of Sgo1p was observed upon Ipl1p depletion, and it
was shown that Sgo1p actually recruits Ipl1p to meiotic
centromeres [57]. Fission yeast studies also demonstrated an
interdependence between Passenger proteins and Sgo2p
targeting to centromeres, and in those experiments Survivin
appears to be the Passenger protein most closely linked to
Sgo2p [58,59].
Because of these links with the Passenger proteins, we have
carried out preliminary experiments, looking at the Ipl1p and
Sli15p in budding yeast mitotic cells that lack the Bub1 kinase
domain. Whilst there may be subtle effects on the efﬁciency
of recruitment of the Passenger proteins to mitotic centro-
meres, we ﬁnd these to be far less signiﬁcant than the effects
on Sgo1p (Figure S4, and unpublished data). Thus we doubt
that Factor X is one of the Passenger proteins (see models in
Figure 6). Experiments to identify this factor are ongoing.
Bub1 Kinase and Sgo1 Are Required for Efficient
Chromosome Biorientation following Nocodazole
Treatment
We have demonstrated that both bub1DK and sgo1D
mutants have a defect in chromosome biorientation upon
nocodazole release (Figure 5). In many of the mitotic cells we
observed chromosomes that fail to biorient, lying close to one
of the SPBs. One explanation could be that these mutants fail
to detect or respond to inappropriate attachments, for
example syntelic attachments that lack tension. This hypoth-
esis is supported by the fact that bub1DK and sgo1D cells lack
the ability to delay anaphase onset in response to tension
defects induced by reduced cohesion (Figure 2 and [39]).
Alternatively, bub1DK and sgo1D cells may sense these defects
but be unable to break the inappropriate kinetochore-
microtubule attachments. The Yen lab have recently demon-
Figure 6. Models for Bub1 Kinase and Sgo1p Functions
(A) Simple linear pathway: Bub1 kinase phosphorylates Factor X in such a
way that Sgo1 is efficiently targeted to centromeres. This in turn ensures
efficient recruitment of the Passenger proteins, which act to monitor and
correct any inappropriate kinetochore-microtubule attachments.
(B) Parallel pathways: Bub1 kinase, Sgo1p, and the Passenger proteins act
in a concerted fashion to ensure efficient biorientation of sister
kinetochores. This model better explains why localization of the different
proteins are not entirely dependent upon one another. It also suggests
that Bub1 kinase, and/or Sgo1p, might act to break inappropriate
kinetochore attachments independently of Aurora kinase.
doi:10.1371/journal.pgen.0030213.g006
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strated that human Sgo2 is not required to recruit Passenger
proteins to centromeres but is needed to recruit the kinesin
MCAK [60]. The activity of that kinesin, which is an Aurora B
substrate, is known to be important for breaking inappro-
priate kinetochore attachments in some systems [61,62]. In
addition, Sgo proteins have been shown to bind directly to
microtubules and to modulate kinetochore-microtubule
dynamics [63], so it is also possible that Sgo1p has a direct
role in breaking microtubule attachments.
Bub1 kinase and Sgo1p could be part of the pathway that
employs the Passenger proteins to destabilise kinetochore-
microtubule attachments that lack tension. If so, one would
expect similar phenotypes between bub1DK, sgo1D, and
Passenger protein mutants. There are striking similarities:
(1) ipl1 and sli15 mutants can arrest the cell cycle in response
to unattached kinetochores because of nocodazole treatment,
and (2) ipl1 mutants fail to delay anaphase onset when
cohesion is reduced and there is a lack of tension at
kinetochores [23,64]. However, the Passenger proteins are
essential, and are required for response to ‘‘core’’ kineto-
chore attachment defects, such as those present in ndc80–1
and mtw1–1 [24]. Figure 6 contains models that attempt to
explain these observations.
In certain circumstances, such as those found during
spindle assembly upon nocodoazole washout, the activity of
Bub1 kinase and Sgo1p become necessary to ensure complete
biorientation. Our data show that Bub1 kinase is required for
efﬁcient localisation of Sgo1p to centromeres, which in turn
may aid efﬁcient targeting of the Passenger proteins or their
targets. Such a mode of action places Bub1p, Sgo1p and the
Passengers in a simple linear pathway (Figure 6A). However,
due to the lack of a clear effect on Passenger protein
localisation, we currently favour an alternative model in
which Bub1p, Sgo1p and the Passengers act cooperatively, but
in distinct pathways, to ensure efﬁcient biorientation (Figure
6B). The identiﬁcation of direct Bub1 kinase substrates will be
key to a deeper understanding of the role(s) of Bub1 kinase in
the complex regulation of kinetochore attachment and error
correction in mitosis.
Materials and Methods
Yeast strains, media, and standard techniques. The yeast strains
used in this study are derivatives of W303 (ade2–1 his3–11 leu2–112
trp1–1 can1–100 ssdl-d2) and are listed in Table 1. Yeast strains were
grown in YPDA or selective media, and other basic yeast methods
have been previously described. For synchronisation of cells in G1 we
used 1 lg/ml a-factor for bar1 and 10 lg/ml a-factor BAR1 strains.
Tagging of Spc42-Tomato (strains JF152, JF154, and JF156) was
performed using cassettes described in [65,66].
Creation of bub1DK allele. Amino acids 609–1,021 were truncated
by PCR-mediated gene disruption, using pFA6a-Hygromycin resist-
ance cassette [67] and veriﬁed by PCR and sequencing. The sgo1D
strain was created using pFA6-kanMX6 [68].
Checkpoint assays. Benomyl, microcolony, and viability assays were
all performed as previously described [9,41,69]. The mtw1–1 check-
point activation assay was performed as in [24]. The depletion of
cohesin (lack of tension) assay was performed using GAL-MCD1 as
described [39].
A linear minichromosome assay was employed essentially as
described in [39]. The linear chromosome used (pA241) is marked
with LEU2. Such chromosomes have been shown to delay mitosis in a
checkpoint-dependent manner [42] and were employed in a screen
that identiﬁed sgo1 alleles [39]. In the strains used here, and for the
screen, the linear chromosome-induced delay becomes lethal as the
cells also contain CDC28-VF, a mutation in CDC28/CDK1 that reduces
APC activity. This lethality is rescued by checkpoint mutations, as no
mitotic delay is imposed. In addition, doxycycline represses a
dominant CDC20 allele that is insensitive to the spindle checkpoint
proteins because it contains a mutation in the Mad2p binding site
[13]. This means that all strains (wild-type or checkpoint mutant)
containing the LMCs can be propagated in the absence of
doxycycline. When doxycycline is added only wild-type CDC20 is
expressed: if the strain is checkpoint proﬁcient it will not form
colonies.
Chromosome segregation assays. Strains containing GFP-marked
Chromosome IV was presynchronised in G1 and a sample was ﬁxed in
3.7% formaldehyde for 5 min. The cells were then released into 30 lg/
ml nocodazole and grown at 23 8C for 3 h. The nocodazole was then
washed out, three times with YPDA media and then arrested in the
next G1, and another sample was ﬁxed as above. The same strain was
used to analyse chromosome segregation at the ﬁrst anaphase after
nocodazole arrest. Cells were again presynchronised in G1 and
arrested with nocodazole as above. Cells were released and ﬁxed for 1
h in 3.7% formaldehyde and washed with 0.1 M potassium phosphate
(pH 7.5). Then they were treated with 50 lg/ml Zymolyase 100,000 in
0.1 M potassium phosphate/0.7 M Sorbitol. General immunoﬂuor-
escence was performed as previously described in [69]. Quantitative
chromosome mis-segregation assay (sectoring assay) was performed as
previously described [30,47].
Chromosome spreads. Chromosome spreads were performed on
cycling cells and on nocodazole arrested cells as previously described
by [70,71]. Sgo1-9myc was detected using rabbit anti-myc antibody
(CM-100, Gramsch) at a 1:800 dilution, and anti-rabbit Alexa Fluor
488 (Invitrogen) at a 1:1,000 dilution. Ndc10-6HA was detected using
a mouse anti-HA antibody (HA11, BabCO) at a 1:200 dilution and
anti-mouse Alexa Fluor 594 (Invitrogen) at a 1:1,000 dilution. The
spindle pole bodies were marked using an anti-Spc110 antibody at a
1:50 dilution (kind gift from John Kilmartin) and anti-mouse Alexa
Fluor 594 (Invitrogen) at a 1:1,000 dilution.
ChIP. Cells were arrested for 3 h in 15 lg/ml nocodazole and 30 lg/
ml benomyl, and 50 ml cells were collected for ChIP. SGO1- 6HA
ChIPs were performed using 12CA5 anti-HA antibody (Roche), and
the general protocol including primers was performed as described
in [72].
Chromosome attachment assay. Similar experiments to those
described in [24] were performed, where the mitotic spindle is
labelled with tubulin-CFP and the kinetochores with Mtw1-3xGFP.
Strains were treated with 15 lg/ml nocodazole and 30 lg/ml benomyl
at 23 8C for 3 h. Cells were then washed three times and grown in
YPDA at 30 8C for 20 min, then ﬁxed in 3.7% formaldehyde for 5 min.
ndc80–1 cells were grown for the last 90 min at the restrictive
temperature of 36 8C.
Chromosome biorientation assay. Strains were arrested in G1 in
medium lacking methionine for 3 h, then transferred to YPDA media
plus 8 mM methionine for 2 h at 30 8C to deplete Cdc20. The a-factor
was subsequently washed out, and cells were then incubated at 23 8C
for 3 h in media containing 30 lg/ml benomyl, 30 lg/ml nocodazole,
and 8mM methionine. The microtubule drugs were then washed out,
and the spindle was allowed to reform at 30 8C in YPDA media plus 8
mM methionine. Cells were ﬁxed at indicated times in 3.7%
formaldehyde for 5 min. The GFP dots were analysed only in cells
that had a short bipolar spindle (i.e., two SPBs) to score for
biorientation. These experiments were repeated at least three times,
and at each time point 100 cells were counted.
Supporting Information
Figure S1. bub1DK Cells Initiate and Maintain a Robust Checkpoint
Arrest in Response to Antimicrotubule Drugs
(A) Wild-type (KH186), bub1DK (JF098), bub1D (KH127), and mad2D
(KH141) yeast strains were analysed for growth on YPDA media
containing (A) 20 lg/ml or (B) 80 lg/ml benomyl grown at 23 8C. We
scored the percentage of cells that remain arrested (large-budded)
throughout the time course (n ¼ 50 cells). The bub1DK cells initiate
and maintain a robust checkpoint arrest.
Found at doi:10.1371/journal.pgen.0030213.sg001 (49 KB PDF).
Figure S2. Sgo1 Localisation to Kinetochores (Ndc10) Is Defective in
bub1DK
(A) Wild-type (AMY1110), bub1DK (JF038), and bub1D (AMY1379) cells
were harvested in log-phase, and staining was performed on
chromosome spreads. Anti-myc (CM-100) was used to detect Sgo1-
9myc, and anti-HA (HA11) was used to detect Ndc10-6HA. Cells with
clear Ndc10-6HA staining were categorised as either having
colocalisation with Sgo1-9myc (left panel), or only partial colocalisa-
PLoS Genetics | www.plosgenetics.org November 2007 | Volume 3 | Issue 11 | e2132322
Bub1 Kinase and Biorientation
tion that could be due to spindle pole bodies (right panel). The
spreads with no Sgo1 staining are not shown but were similar in
number in wild type and bub1DK mutant.
(B) Quantiﬁcation of spreads scoring percentage of spreads that
showed colocalisation of Sgo1 to the Ndc10 kinetochore marker.
Error bars indicate standard deviation of the mean.
Found at doi:10.1371/journal.pgen.0030213.sg002 (66 KB PDF).
Figure S3. Mcd1 Cleavage Is Not Defective in bub1DK Cells
Wild-type (AMY1145) and bub1DK (JF216) strains were arrested in
mitosis using 15 lg/ml nocodazole and 30 lg/ml benomyl at 23 8C for
3 h. The drug was washed out and samples for immunoblotting with
12CA5 (anti-HA antibody) were taken at indicated timepoints. There
was no signiﬁcant difference in timing or amount of Mcd1 cleavage
detected. Blot shows a representative experiment. The experiment
was repeated three times.
Found at doi:10.1371/journal.pgen.0030213.sg003 (124 KB PDF).
Figure S4. Kinetochore Localisation of Ipl1 Kinase Is Not Signiﬁ-
cantly Perturbed in bub1DK Cells
Wild-type (T5241) and bub1DK (JF169) strains were arrested in mitosis
using 15 lg/ml nocodazole and 30 lg/ml benomyl. Kinetochores were
marked using Ctf19-CFP and Ndc80-CFP. There was no signiﬁcant
reduction of Ipl1-GFP on kinetochores in the bub1DK strain
compared to wild-type cells.
Found at doi:10.1371/journal.pgen.0030213.sg004 (196 KB PDF).
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Table 1. Yeast Strains
Strain Genotype
KH186 ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1
KH141 mad2D::URA3 ade2-1 his3-11,15 leu2-3,112 trp1-1
KH173 mad3D2::URA3 bar1 ade2-1 his3-11,15 leu2-3,112 trp1-1
KH127 bub1D::HIS3 ade2-1 leu2-3,112 trp1-1 ura3-1
JF098 bub1DK::HPH bar1 ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
MB003 bub3D::LEU2 ade2-1 his3-11 trp1-1 ura3-1
MB076 mad1D::URA3 ade2-1 his3-11,15 leu2-3,112 trp1-1
JF004 trp1-1:lacO::URA GFPlacI::HIS3 Pds1-Myc18::LEU ade2-1 leu2-3,112
JF125 bub1DK::HPH LacO::URA GFP-LacI::HIS Pds1-Myc18::LEU ade2-1 leu2-3,112 trp1-1
JF140 bub1D::HPH LacO::URA GFP-LacI::HIS Pds1-Myc18::LEU ade2-1 leu2-3,112 trp1-1
EK013 mad3D2::URA3 his3-11:pCUP-GFP12-lacI12:HIS3 trp1-1:lacO::TRP1 leu2,3-112 ade2-1 bar1
JF152 pURA3-tetR::GFP::LEU2 cenIV::tetO(x448)::URA3 METprom-CDC20::URA Spc42-Tomato::NAT ade2-1 leu2-3,112 ura3-3 trp1-1 his3-11,15
JF154 pURA3-tetR::GFP::LEU2 cenIV::tetO(x448)::URA3 METprom-CDC20::URA Spc42-Tomato::NAT bub1DK::HPH bar1 ade2-1 leu2-3 ura3 trp1-1 his3-11,15
JF156 pURA3-tetR::GFP::LEU2 cenIV::tetO(x448)::URA3 METprom-CDC20::URA Spc42-Tomato::NAT sgo1D::KAN ade2-1 leu2-3,112 ura3-3 trp1-1 his3-11,15
JF202 pURA3-tetR::GFP::LEU2 cenIV::tetO(x448)::URA3 METprom-CDC20::URA Spc42-Tomato::NAT sgo1D::KAN bub1DK::HPH
ade2-1 leu2-3,112 ura3 trp1-1 his3-11,15
KH231 þCFIII (CEN3.L.YPH278) URA3 SUP11 bar1 ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
RJ112 þCFIII (CEN3.L.YPH278) URA3 SUP11 bar1 bub1D::HIS3 ade2-1 his3 11,15 leu2-3,112 trp1-1 ura3-1
JF129 þCFIII (CEN3.L.YPH278) URA3 SUP11 bar1 bub1DK::HPH ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
JF190 þCFIII (CEN3.L.YPH278) URA3 SUP11 bar1 bub1DK::HPH sgo1D::kanMX ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
JF200 þCFIII (CEN3.L.YPH278) URA3 SUP11 bar1 sgo1D::kanMX ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
SBY1646 mtw1-1 his3-11pCUP1GFP12-lacI12:HIS3 trp1-1 256 lacO::TRP1 PDS1-myc18::LEU2 bar1 ade2-1 ura3-1
SBY1724 mtw1-1 his3-11pCUP1GFP12-lacI12:HIS3 trp1-1 256 lacO::TRP1 PDS1-18myc18::LEU2 ipl1-321 bar1 ade2-1 ura3-1
JF100 mtw1-1 bub1DK::HPH his3-11pCUP1GFP12-lacI12:HIS3 trp1-1 256 lacO::TRP1 PDS1-myc18::LEU2 ade2-1 ura3-1 bar1
AMY1110 Sgo1-Myc9::TRP1 Ndc10-6HA::TRP1 ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
AMY1379 Sgo1-Myc9::TRP1 Ndc10-6HA::TRP1 bub1::kanMX6 ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
JF038 Sgo1-Myc9::TRP1 Ndc10-6HA::TRP1 bub1DK::HPH ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
SBY4340 Mtw1-3xGFP::HIS3 ura3-1-TUB-CFP::URA3 bar1 ade2-1 his3-11,15 leu2-3,112 trp1-1
SBY4342 Mtw1-3xGFP::HIS3 ura3-1-TUB-CFP::URA3 ndc80-1 bar1 ade2-1 his3-11,15 leu2-3,112 trp1-1
JF123 Mtw1-3xGFP::HIS3 ura3-1-TUB-CFP::URA3 bub1DK::HPH bar1 ade2-1 his3-11,15 leu2-3,112 trp1- 1
JF202 Mtw1-3xGFP::HIS3 ura3-1-TUB-CFP::URA3 sgo1D::kanMX bar1 ade2-1 his3-11,15 leu2-3,112 trp1-1
JF188 sgo1D::kanMX bar1 ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
JF185 sgo1D::kanMX bub1DK::HPH bar1 ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
T5241 IPL1-GFP::kanMX CTF19-3CFP::HISMX6 NDC80-3CFP::HIS3 ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
JF169 IPL1-GFP::kanMX CTF19-3CFP::HISMX6 NDC80-3CFP::HIS3 bub1DK::HPH ade2-1 his3-11,15 leu2-3,112 trp1-1, ura3-1
AMY209 SGO1-6HA::TRP ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
JF211 SGO1-6HA::TRP bub1DK::HPH ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
AMY1145 MCD1-6HA ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
JF216 MCD1-6HA bub1DK::HPH ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
VBI545 Pds1-myc::LEU lacO::TRP GFPlacI::HIS3 pGAL-MCD1::kanMX bar1 ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
VBI560 Pds1-myc::LEU lacO::TRP GFPlacI::HIS3 pGAL-MCD1::kanMX mad2D::kanMX bar1 ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
JF023 Pds1-myc::LEU lacO::TRP GFPlacI::HIS3 pGAL-MCD1::kanMX bub1DK::HPH bar1 ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
JF224 Pds1-myc::LEU lacO::TRP GFPlacI::HIS3 pGAL-MCD1::kanMX sgo1D::kanMX bar1 ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
YBS151 CDC28-VF::HIS3 tet02-CDC20-127::TRP1 pA241 CEN ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
YBS406 CDC28-VF::HIS3 tet02-CDC20-127::TRP1 pA241 CEN mad2D::kanMX ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
JF110 CDC28-VF::HIS3 tet02-CDC20-127::TRP1 pA241 CEN bub1DK::HPH ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1
doi:10.1371/journal.pgen.0030213.t001
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